Literature DB >> 2285586

Modulation of oestrogen receptor activity by oestrogens and anti-oestrogens.

S Green1.   

Abstract

The oestrogen receptor is a member of a supergene family that includes receptors for steroid and thyroid hormones, vitamin D3, and retinoic acid. A number of additional members of the family have been cloned where the putative ligand remains to be identified. The oestrogen receptor is a ligand-activated transcription factor that modulates specific gene expression by binding to short DNA sequences (oestrogen response elements) located in the vicinity of oestrogen-regulated genes. Regions of the receptor responsible for hormone-binding. DNA-binding and activation of transcription, have been identified. The anti-oestrogen, tamoxifen (Nolvadex), behaves as a weak oestrogen agonist. A model, based upon our current understanding of the molecular mechanism of oestrogen action, will be presented to explain the cell and gene specific effects of some anti-oestrogens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285586     DOI: 10.1016/0960-0760(90)90415-h

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  5 in total

1.  A case of painless thyroiditis possibly triggered by tamoxifen citrate, a synthetic antiestrogen.

Authors:  H Watanobe; H Kawabe
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

2.  Combined effects of 1,25-dihydroxyvitamin D3 and tamoxifen on the growth of MCF-7 and ZR-75-1 human breast cancer cells.

Authors:  T Vink-van Wijngaarden; H A Pols; C J Buurman; J C Birkenhäger; J P van Leeuwen
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

Review 3.  Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

Authors:  V C Jordan
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

4.  Stimulation of erythropoiesis by the non-steroidal anti-androgen nilutamide in men with prostate cancer: evidence for an agonistic effect?

Authors:  A Decensi; R Torrisi; V Fontana
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

5.  New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.

Authors:  Margarida Cepa; Georgina Correia-da-Silva; Elisiário J Tavares da Silva; Fernanda M F Roleira; Margarida Borges; Natércia A Teixeira
Journal:  BMC Cell Biol       Date:  2008-07-24       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.